2004
DOI: 10.1097/01.rlu.0000109298.69905.04
|View full text |Cite
|
Sign up to set email alerts
|

Trimetazidine Improves Myocardial Perfusion and Left Ventricular Function in Ischemic Left Ventricular Dysfunction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2006
2006
2015
2015

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…Thus, we employed a test protocol that entails the administration of both trimetazidine and nitroglycerin before radiotracer injection. A recent study by Feola et al showed that the addition of trimetazidine to 99m Tc-tetrofosmin scintigraphy improved the sensitivity of the perfusion scan for the detection of viable myocardial tissue, both at 2- and 6-months follow-up, compared with placebo, maintaining a satisfactory specificity ( 17 ). Furthermore, the predictive power of 99m Tc-sestamibi scintigraphy was also enhanced with the addition of nitrates, obtaining an improvement in both the sensitivity and specificity (up to 95 and 88%, respectively) ( 18 ).…”
Section: Discussionmentioning
confidence: 99%
“…Thus, we employed a test protocol that entails the administration of both trimetazidine and nitroglycerin before radiotracer injection. A recent study by Feola et al showed that the addition of trimetazidine to 99m Tc-tetrofosmin scintigraphy improved the sensitivity of the perfusion scan for the detection of viable myocardial tissue, both at 2- and 6-months follow-up, compared with placebo, maintaining a satisfactory specificity ( 17 ). Furthermore, the predictive power of 99m Tc-sestamibi scintigraphy was also enhanced with the addition of nitrates, obtaining an improvement in both the sensitivity and specificity (up to 95 and 88%, respectively) ( 18 ).…”
Section: Discussionmentioning
confidence: 99%
“…In patients with myocardial ischemia, TMZ improves myocardial perfusion, increases the left ventricular ejection fraction and reduces the residual left ventricular end-systolic volume [17]. Furthermore, when used during thrombolysis in patients with acute myocardial infarction, TMZ reduces reperfusion injury.…”
Section: Discussionmentioning
confidence: 99%